Firstly, I wish to apologise for only coming here when *I* have news. I will try to be a better participant going forward.

Unfortunately, after having had very good results at my 3-month follow-up PET-CT scan (nothing to see here, move along) I've had a dramatically different result at my 6-month PET-CT, in that it appears my SCC has come roaring back and spread around my left lung within my pleura, and with one additional spot down probably on my bowel.

Oops.

I feel quite well, aside from some nagging minor 'pleurisy' and a touch of 'asthma', alas, not so much.

Learned all of this last week Thursday night. Yesterday I met with the Drug Development Unit at the Royal Marsden Hospital in Sutton, Surrey, and while it's not finally confirmed, they feel I'm a very strong candidate for a 'promising' new 'targeted' anti-cancer drug by Genentech that's under Stage 1 trials. It's just called GDC - 0980, and it targets a certain 'pathway' in the cancer's mechanism, rather than just shotgun poisoning any and all quick-dividing cells, as traditional chemo does. This means that the side effects should be much less, although of course, it's experimental, so anything could happen.

Presuming this goes ahead, my trial would start in early January.

Onward through the fog!

Hugs to everybody.

-Seth

47 yr old male non-smoker, social drinker, fit. Jan'10, Stg3 rt tonsil+rt neck SCC, HPV+, rad+chmo Vancouver Cda. 2yr clear Apr'12 London UK. Apr'13 mets recur to lymph btw left lung & aorta, 3x Cisplatin+5FUchemo+20 rad, was all clear but 6-mo PET-CT shows mets to pleura around left lung, participating in St 1 trial of GDC-0980. GDC lost effect and ended July'14, bad atrial fibrillation requiring hospitalisation, start more standard chemo 10 Sep 2014.
Sadly has passed away, notified Jan 2015.